Moody's Q3 Shows Stalled Growth and Margin Compression, Triggering Sell Downgrade

What happened

Moody's Corporation's third quarter 2026 results revealed revenue growth of just 1% and declining operating margins, a sharp deceleration from the 8% growth seen in the first nine months of 2025. This slowdown, coupled with years of underperformance and a deteriorating business mix, led Seeking Alpha to downgrade the stock to Sell. The company's valuation remains demanding at nearly 30 times forward earnings, despite muted growth prospects. The deterioration confirms the cyclical risk previously highlighted in the DeepValue report, which noted earnings' tight linkage to debt issuance volumes. With the market now pricing in a recovery that has yet to appear, the risk/reward has shifted decisively against shareholders.

Implication

The combination of stalled revenue growth, margin compression, and a still-elevated valuation indicates that the market's expectations are out of sync with reality. Existing holders should consider trimming positions, while potential buyers should remain patient and wait for either a material pullback or clear evidence of a turnaround in issuance volumes and margin stability. The regulatory and AI-driven competitive threats flagged in the prior report have likely intensified, adding to the downside risk. While Moody's strong cash flow and oligopoly status provide some long-term support, the near-term setup is unfavorable. Key monitoring metrics include quarterly MIS issuance volumes, MA ARR growth, and any signs of margin recovery.

Thesis delta

The prior DeepValue analysis labeled Moody's a 'POTENTIAL SELL' due to rich valuation and cyclical exposure. The latest Q3 data validate that concern, with revenue growth collapsing to 1% and margins declining. Consequently, the thesis has shifted from a cautious potential sell to a firmer sell, as the fundamental deterioration has begun to materialize and the valuation has not yet corrected sufficiently.